Rationale for the use of immunomodulatory therapies in the Global Initiative for Asthma (GINA) step V asthma other than oral glucocorticosteroids.
about
Molecular biomarkers for grass pollen immunotherapy.Weekly low-dose methotrexate for reduction of Global Initiative for Asthma Step 5 treatment in severe refractory asthma: study protocol for a randomized controlled trialPrevalence of bronchiectasis in asthma according to oral steroid requirement: influence of immunoglobulin levels.Effect of Kuwanon G isolated from the root bark of Morus alba on ovalbumin-induced allergic response in a mouse model of asthma.Omalizumab Treatment for Atopic Severe Persistant Asthma: A Single-Center, Long-Term, Real-Life Experience with 38 Patients
P2860
Rationale for the use of immunomodulatory therapies in the Global Initiative for Asthma (GINA) step V asthma other than oral glucocorticosteroids.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Rationale for the use of immun ...... han oral glucocorticosteroids.
@en
Rationale for the use of immunomodulatory therapies in the Global Initiative for Asthma
@nl
type
label
Rationale for the use of immun ...... han oral glucocorticosteroids.
@en
Rationale for the use of immunomodulatory therapies in the Global Initiative for Asthma
@nl
prefLabel
Rationale for the use of immun ...... han oral glucocorticosteroids.
@en
Rationale for the use of immunomodulatory therapies in the Global Initiative for Asthma
@nl
P2093
P2860
P1476
Rationale for the use of immun ...... han oral glucocorticosteroids.
@en
P2093
P2860
P304
P356
10.1111/J.1445-5994.2011.02481.X
P577
2011-07-01T00:00:00Z